These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 35752307)
21. Baseline Toxicity Model to Identify the Specific and Nonspecific Effects of Per- and Polyfluoroalkyl Substances in Cell-Based Bioassays. Qin W; Henneberger L; Glüge J; König M; Escher BI Environ Sci Technol; 2024 Apr; 58(13):5727-5738. PubMed ID: 38394616 [TBL] [Abstract][Full Text] [Related]
22. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis. Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043 [TBL] [Abstract][Full Text] [Related]
23. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Takacs ML; Abbott BD Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030 [TBL] [Abstract][Full Text] [Related]
24. Transactivation potencies of the Baikal seal (Pusa sibirica) peroxisome proliferator-activated receptor α by perfluoroalkyl carboxylates and sulfonates: estimation of PFOA induction equivalency factors. Ishibashi H; Kim EY; Iwata H Environ Sci Technol; 2011 Apr; 45(7):3123-30. PubMed ID: 21381677 [TBL] [Abstract][Full Text] [Related]
25. Investigating the cytotoxicity of per- and polyfluoroalkyl substances in HepG2 cells: A structure-activity relationship approach. Amstutz VH; Cengo A; Gehres F; Sijm DTHM; Vrolijk MF Toxicology; 2022 Oct; 480():153312. PubMed ID: 36075290 [TBL] [Abstract][Full Text] [Related]
26. Identifying novel mechanisms of per- and polyfluoroalkyl substance-induced hepatotoxicity using FRG humanized mice. Robarts DR; Paine-Cabrera D; Kotulkar M; Venneman KK; Gunewardena S; Foquet L; Bial G; Apte U Arch Toxicol; 2024 Sep; 98(9):3063-3075. PubMed ID: 38782768 [TBL] [Abstract][Full Text] [Related]
27. The impact of legacy and novel perfluoroalkyl substances on human cytochrome P450: An in vitro study on the inhibitory potential and underlying mechanisms. Amstutz VH; Cengo A; Sijm DTHM; Vrolijk MF Toxicology; 2022 Feb; 468():153116. PubMed ID: 35121066 [TBL] [Abstract][Full Text] [Related]
28. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists. Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681 [TBL] [Abstract][Full Text] [Related]
29. Effects of legacy and emerging per- and polyfluoroalkyl substances on PPARα/β/γ regulation and osteogenic/adipogenic differentiation. Qin H; Niu Y; Luan H; Li M; Zheng L; Pan Y; Liu W Environ Int; 2022 Dec; 170():107584. PubMed ID: 36265359 [TBL] [Abstract][Full Text] [Related]
30. Transcriptional effects of binary combinations of PFAS in FaO cells. Bjork JA; Dawson DA; Krogstad JO; Wallace KB Toxicology; 2021 Dec; 464():152997. PubMed ID: 34695511 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA. Heintz MM; Chappell GA; Thompson CM; Haws LC Front Toxicol; 2022; 4():937168. PubMed ID: 35832492 [TBL] [Abstract][Full Text] [Related]
32. Dose additive maternal and offspring effects of oral maternal exposure to a mixture of three PFAS (HFPO-DA, NBP2, PFOS) during pregnancy in the Sprague-Dawley rat. Conley JM; Lambright CS; Evans N; Farraj AK; Smoot J; Grindstaff RD; Hill D; McCord J; Medlock-Kakaley E; Dixon A; Hines E; Gray LE Sci Total Environ; 2023 Sep; 892():164609. PubMed ID: 37271399 [TBL] [Abstract][Full Text] [Related]
33. Tumorigenic activity of alternative per- and polyfluoroalkyl substances (PFAS): Mechanistic in vitro studies. Pierozan P; Cattani D; Karlsson O Sci Total Environ; 2022 Feb; 808():151945. PubMed ID: 34843762 [TBL] [Abstract][Full Text] [Related]
34. Hepatic Transcriptome Comparative In Silico Analysis Reveals Similar Pathways and Targets Altered by Legacy and Alternative Per- and Polyfluoroalkyl Substances in Mice. Robarts DR; Dai J; Lau C; Apte U; Corton JC Toxics; 2023 Nov; 11(12):. PubMed ID: 38133364 [TBL] [Abstract][Full Text] [Related]
35. Perfluoroalkyl substances and immunotoxicity: An in vitro structure-activity relationship study in THP-1-derived monocytes and macrophages. Amstutz VH; Sijm DTHM; Vrolijk MF Chemosphere; 2024 Sep; 364():143075. PubMed ID: 39151576 [TBL] [Abstract][Full Text] [Related]